Tumor cell migration is a crucial step in the metastatic cascade, and interruption of this step is considered to be logically effective in preventing tumor metastasis. Lipid rafts, distinct liquid ordered plasma membrane microdomains, have been shown to influence cancer cell migration, but the underlying mechanisms are still not well understood. Here, we report that lipid rafts regulate the dynamics of actin cytoskeleton and focal adhesion in human melanoma cell migration. Disrupting the integrity of lipid rafts with methyl-β cyclodextrin enhances actin stress fiber formation and inhibits focal adhesion disassembly, accompanied with alterations in cell morphology. Furthermore, actin cytoskeleton, rather than microtubules, mediates the lipid raft-dependent focal adhesion disassembly by regulating the dephosphorylation of focal adhesion proteins and the internalization of β3 integrin. We also show that Src-RhoA-Rho kinase signaling pathway is responsible for lipid raft disruption-induced stress fiber formation. Taken together, these observations provide a new mechanism to further explain how lipid rafts regulate the migration of melanoma cell and suggest that lipid rafts may be novel and attractive targets for cancer therapy.
Introduction
Metastasis is the major cause of cancer mortality. To metastasize, cancer cells must use their intrinsic migratory ability to invade adjacent tissues and the vasculature [1] . Therefore, understanding the molecular mechanisms regulating the migration of cancer cells is very important for anti-metastasis therapy.
The migration of cancer cells on substrate is the sum of several temporally and spatially coordinated processes, which include protrusion of the leading edge, adhesion of the leading edge to the substrate, movement of cell body, and release from contact sites at the trailing edge [2] . During these processes, the dynamics of actin cytoskeleton and focal adhesion are generally thought to play pivotal roles. The remodeling of actin cytoskeleton provides a driving force to push membrane forward at the leading edge and a traction force to move the cell body [3] . The formation of focal adhesions at cell front anchors membrane protrusions and their disassembly releases adhesions at the rear of the cells, which are required for cell relocation and forward progression, respectively [4] [5] [6] . Furthermore, actin cytoskeleton shows a close relationship with focal adhesion dynamics in cell migration. On the one hand, the actin cytoskeleton forms the intracellular scaffold for focal adhesions and provides the tension for their growth [7, 8] . On the other hand, dendritic actin depolymerization results in disassembly of focal adhesions in the lamellipodium [9] . Thus, the factors influencing the remodeling of actin cytoskeleton are also potential regulators of focal adhesion dynamics.
One of the probable factors concerns cholesterol and sphingolipid enriched membrane microdomains, so-called lipid rafts, which form compartmental platforms for cellular signaling and protein-protein or protein-lipid interaction. Previous reports showed that lipid rafts can concentrate membrane lipids and some proteins, such as phosphatidylinositol 4, 5-bisphosphate and Pyk2/Cbl, and regulate the dynamics of actin cytoskeleton in T cell activation and neurites growth [10, 11] . Recently, lipid rafts have been reported to promote cell migration in non-small cell lung cancer by incorporating focal adhesion molecules, such as FAK and Src, into raft fractions [12] . Also, it is increasingly clear that lipid rafts are implicated in the dynamic processes of internalization and recycling of cell-surface integrin which is the structural and functional core of focal adhesion and bridges focal adhesion with actin cytoskeleton in cell migration [13] [14] [15] [16] . Despite recent significant advancements, the question of whether lipid rafts regulate focal adhesion dynamics through modulating actin cytoskeleton in cancer cell migration and the underlying mechanisms have not been well characterized.
In the present study, we demonstrate that lipid rafts contribute to focal adhesion disassembly by Src-RhoA-Rho kinase (ROCK) signaling pathway-mediated actin cytoskeleton dynamics, which is crucial for human melanoma cell migration. Because targeting lipid rafts for cancer therapy has been suggested [17] , the findings of this study provide a potential strategy for treating melanoma via modulating lipid rafts.
Materials and methods

Reagents and plasmids
Methyl-β cyclodextrin (MβCD), cholesterol, cytochalasin D (CD), 4-Morpholineethanesulfonic acid (MES), mAbs to phosphotyrosine (PY20), vinculin (V4505), tubulin (T4026) and actin (A5441) were purchased from Sigma-Aldrich. C3 exoenzyme was purchased from Cytoskeleton. Glutathione-Sepharose 4B beads were purchased from Amersham Biosciences. Polyclonal antibody to paxillin (Ab-88) was purchased from Signalway Antibody. Y27632, mAbs to β1 integrin (TDM29) and β3 integrin (LM609) were purchased from Millipore. mAbs to paxillin (D-9), RhoA (26C4), Src (H-12) and flotillin-2 (B-6) and polyclonal antibodies to vinculin (H-300), Rac1 (C-14) and Cdc42 (B-8) were purchased from Santa Cruz Biotechnology. Rhodamineconjugated phalloidin was purchased from Molecular Probes. GFPvinculin plasmid was generously provided by Dr. Bernd Hoffmann (Institute of Bio-and Nanosystems, Germany). The GST-tagged expression plasmid pGEX-Rho binding domain of Rhotekin (Rhotekin-RBD) and the plasmid encoding a constitutively active form of RhoA (pcDNA-RhoA-Q63L) were kindly provided by Dr. Cindy K Miranti (Van Andel Research Institute, USA). The GST-tagged expression plasmid pGEX-p21 binding domain of p21-activated kinase 1 (PAK1-PBD) was a kind gift from Dr. Gary Bokoch (The Scripps Research Institute, La Jolla, CA, USA).
Cell culture and transient transfection
Human melanoma A375 cells were purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Science (Shanghai, China). Human melanoma M21 cells were from the School of Basic Medical Sciences, Jilin University of China. The cells were cultured in DMEM containing 10% FBS at 37°C with 5% CO 2 . Cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Wound healing assay
Cells were grown in 24-well culture plates and wounded after reaching confluency using a 10 μl pipette tip. Cells were then washed twice with PBS, incubated with fresh 2% FBS/DMEM containing 5 mM MβCD or not at 37°C. Wound closure was recorded at the indicated time points under phase-contrast microscope (Nikon, Japan) and the images were analyzed using T-Scratch software [18] .
Cell morphology analysis
Cells were seeded on glass coverslips overnight, and then incubated with fresh 2% FBS/DMEM containing 5 mM MβCD or not for different time periods or with 1 mM cholesterol for different time intervals after removal of MβCD. The morphological alteration was investigated using phase-contrast microscope.
Immunofluorescence
Cells plated on glass coverslips overnight were fixed with 10% formaldehyde after treatment with different drugs. Then the cells were permeabilized with 0.1% Triton X-100, blocked in 3% BSA, and incubated with the indicated primary antibodies and fluorochrome-conjugated secondary antibody (Jackson ImmunoResearch Laboratories). The coverslips were mounted and observed under a confocal microscope (Olympus, Japan).
Live cell imaging
Cells grown in 35 mm dishes with 14 mm glass bottom were placed on a 37°C heated stage within a 5% CO 2 atmosphere chamber and sequential images were captured using an UltraVIEW Vox (PerkinElmer Inc., USA) spinning-disk confocal microscope with a Ti-E microscope (Nikon, Japan). Cell migration to scratch wound was monitored in differential interference contrast channel at 30 s intervals over a 6 h time course using a 20× objective. For the observation of focal adhesion dynamics, cells were transiently transfected with a GFP-vinculin vector and cultured for 24 h before imaging in fluorescence channel at 30 s intervals over a 30 min time course using a 40× objective. Kymographs were generated using ImageJ with the Multiple Kymograph function (J. Rietdorf and A. Seitz, European Molecular Biology Laboratory, Heidelberg, Germany).
Immunoprecipitation and immunoblotting
Overnight cultured cells were lysed for 30 min on ice in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 2.5 mM sodium pyrophosphate, 1 mM NaF, 1 mM Na 3 VO 4 , 1 mM β-glycerophosphate, 1 mM PMSF, and 20 μg/ml aprotinin/leupeptin) and centrifuged at 12,000 g for 30 min. The supernatant was incubated with the indicated antibodies at 4°C for 3 h, prior to incubating with 30 μl of protein A/G-Sepharose beads for another 3 h. The immunoprecipitates were separated by SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were blocked in 5% non-fat milk and probed with the appropriate antibody. Blots were then revealed by chemiluminescence (GE Healthcare) after incubation with the HRPconjugated secondary antibodies. Band intensity was quantified by ImageJ.
Internalization assay
Cells were seeded on glass coverslips overnight, and then incubated with β3 integrin antibody for 1 h at 4°C after different treatment. Internalization of antibody-β3 integrin complex was initiated by addition of prewarmed serum-free medium to the cells, followed by incubation at 37°C for 1 h. Surface-bound noninternalized surface antibodies were removed prior to fixation by an acid rinse (0.5% acetic acid, 0.5 M NaCl, pH 3.0, for 5 min). Cells were then permeabilized, and the internalized antibodies were immunostained with fluorochrome-labeled secondary antibody.
Subcellular fractionation
The subcellular fractionation was processed as previously described [19] . Briefly, cells (1 × 10 7 ) treated with different drugs were resuspended in ice-cold hypotonic buffer (42 mM KCl, 10 mM HEPES, pH 7.4, 5 mM MgCl 2 , 20 μg/ml aprotinin/leupeptin) for about 20 min. Then, the cells were homogenized by repeated passage through a 22gauge needle (30 times) and centrifuged at 200 g for 10 min. Cytosolic fractions were obtained by re-centrifuging the supernatants (total fractions) at 13,000 g for 60 min at 4°C. Membrane fractions were obtained by resuspending the pellets in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1 mM PMSF, and 20 μg/ml aprotinin/ leupeptin) and centrifuging at 13,000 g for 60 min at 4°C. The pellets (detergent-insoluble fractions) were lysed in 1% SDS. The different fractions were boiled in Laemmli buffer.
Flow cytometry
Overnight cultured cells were treated with different drugs before harvest. The cells were then fixed with 10% formaldehyde and incubated with anti-β3 integrin antibody or isotype-matched control IgG at room temperature for 1 h. After thorough washes, the cells were stained with FITC-conjugated secondary antibody. The labeled cells were washed with PBS and detected using a FACScan (Beckman-Counter, USA). The data were analyzed by FlowJo software.
Rho GTPase activation assay
The biological activity of Rho GTPase was analyzed using GST pulldown assay as described previously [20] . Briefly, GST-Rhotekin-RBD or GST-PAK1-PBD protein expression was induced with IPTG. GST-Rhotekin-RBD or GST-PAK1-PBD bacteria were resuspended in cold lysis buffer (50 mM Tris, pH 7.5, 1% Triton X-100, 150 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 1 mM PMSF, and 10 μg/ml aprotinin/ leupeptin) and sonicated. After centrifugation, the fusion protein in the supernatant was purified by glutathione-Sepharose 4B beads according to the manufacturer's instructions. Cells treated with 5 mM MβCD or not were lysed and the cell lysates were incubated for 1 h at 4°C with glutathione-Sepharose 4B beads coated with GST-Rhotekin-RBD or GST-PAK1-PBD. Beads were washed with lysis buffer and boiled in Laemmli buffer. The amounts of active RhoA protein bound to GST-Rhotekin-RBD and active Rac1 and Cdc42 proteins bound to GST-PAK1-PBD, as well as the levels present in whole cell lysates, were analyzed by immunoblotting.
Membrane raft preparation
Membrane raft preparation was performed by density gradient centrifugation. Briefly, cells (2 × 10 7 ) were cultured overnight in 10 cm culture plates, then treated with or without 5 mM MβCD for 3 h and lysed on ice by adding lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 1 mM PMSF, 1 μg/ml aprotinin/leupeptin, 50 mM sodium fluoride, 10 mM sodium pyrophosphate, and 1 mM sodium vanadate). The lysates were homogenized with 10 strokes in a Dounce homogenizer and by repeated passage through a 22-gauge needle (30 times). The homogenate (1 ml) was mixed with an equal volume of 80% sucrose in MNE buffer (25 mM MES, pH 6.5, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , 1 mM PMSF, 1 μg/μl of aprotinin), and then overlaid with 2 ml of 30% sucrose followed by 1 ml of 5% sucrose. The gradients were ultracentrifugated (200,000 g at 4°C for 18 h) using a Beckman MLS50 rotor. Twelve fractions (400 μl/fraction) were obtained from the top to bottom and boiled in Laemmli buffer.
Results
Lipid rafts regulate A375 cell morphology and migration
To test whether lipid rafts are involved in human melanoma cell migration, we first performed wound healing assay using A375 cells with 5 mM MβCD treatment, which can disrupt the integrity of lipid rafts by depleting cholesterol [21] . As shown in Fig. 1A and B, control cells briskly migrated into the wound area, reaching 30% and 50% sealing at 6 and 12 h, respectively, after wound scratch. However, the migration velocity of MβCD treated cells was significantly reduced, showing only 13% and 16% sealing at 6 and 12 h after wounding. After 24 h of incubation, control cells filled 90% of the scratched area, while MβCD treated cells only filled 30%. These data demonstrate that the migration of A375 cells requires the integrity of lipid rafts.
To further understand how lipid rafts influence A375 cell migration, we investigated the effect of MβCD treatment on cell morphology, which can reflect the ability of cells to migrate. The results indicated that 75% of control cells were well spread with lamellipodia formation throughout the time frame ( Fig. 1C and D) . However, most of the MβCD treated cells appeared fusiform and smaller than control cells in a time-dependent manner. Approximately 60% of the cells maintained stretched lamellipodia after MβCD treatment for 1 h, and were further reduced to 30% and less than 20% at 2 and 3 h, respectively ( Fig. 1C and D). The cells started to form lamellipodia again when MβCD was removed after 3 h treatment and cholesterol was added. Especially, after 6 h of cholesterol repletion, the number of cells with lamellipodia was rescued to almost control levels ( Fig. 1C and D) . The results of timelapse video microscopy to monitor wound-edge morphology and migration of A375 cells into the scrape wound also showed that control cells formed large lamellipodia and migrated to the wound area rapidly, while cells treated with MβCD appeared fusiform and moved much more slowly (Movies 1 and 2). Taken together, these findings suggest that lipid rafts could regulate A375 cell morphology and migration.
Lipid rafts regulate the dynamics of actin cytoskeleton and the disassembly of focal adhesions
Next, we detected the influence of lipid rafts on the dynamics of actin cytoskeleton and focal adhesion, which are required to maintain cell morphology and promote cell migration. Our results showed that in control cells, filamentous actin (F-actin) assembled around the cell periphery, with a few thin stress fibers located within the cell body ( Fig. 2A, a, upper panel) . The staining for F-actin in cells treated with MβCD for 1 h was comparable to that in control cells ( Fig. 2A , a, lower panel). But the cells with MβCD treatment for 2 h exhibited thick stress fibers which traversed the cell body and by 3 h, the stress fibers became more robust and ordered, accompanied with reduced F-actin staining at the cell periphery ( Fig. 2A, b and c, lower panels). The quantitative analysis of stress fiber density also demonstrated that the number of strong stress fibers significantly increased in the cells treated with MβCD for 3 h (Fig. S1 ), implying that lipid rafts can regulate the dynamics of actin cytoskeleton.
The staining of vinculin, a focal adhesion marker, showed that in control cells and cells with MβCD treatment for 1 h, the appearance and distribution of focal adhesions had no obvious difference. They all displayed small punctate focal adhesions that were mostly prominent at the cell periphery and colocalized with the end of weak stress fibers ( Fig. 2A, a) . However, the focal adhesions in cells treated with MβCD for 2 h became distributed from the cell periphery to the center and colocalized with the end of thicker stress fibers, and larger and longer focal adhesions were found in the cells treated with MβCD for 3 h ( Fig. 2A, b and c, lower panels). Quantitative analysis showed that the average number and size of focal adhesions and the number of large focal adhesions (N 1 μm 2 ) in cells treated with MβCD for 3 h significantly increased compared with control cells (Fig. 2B-D ), suggesting altered focal adhesion disassembly. Therefore, we next examined the effect of lipid rafts on focal adhesion disassembly by monitoring cells expressing GFP-vinculin. Time-lapse video microscopy revealed that GFPvinculin-containing focal adhesions in control cells disassembled much more frequently than that in MβCD treated cells ( Fig. 2E ; Movies 3 and 4). Kymograph analyses further confirmed that A375 cells with MβCD treatment displayed stable focal adhesions compared with the control cells (Fig. 2F) , implying that the disruption of lipid rafts inhibits the disassembly of focal adhesions. In summary, these results indicate that lipid rafts regulate the dynamics of actin cytoskeleton and disassembly of focal adhesions in A375 cells.
The influence of lipid rafts on focal adhesion disassembly is mediated by actin cytoskeleton
Actin cytoskeleton can affect the stability of focal adhesions [7] [8] [9] , which promoted us to investigate whether lipid rafts influence focal adhesion disassembly via regulating actin cytoskeleton. As shown in Fig. 3A , when we treated the cells with CD after removal of MβCD to depolymerize the lipid raft disruption-induced stress fiber, vinculinstained focal adhesions became smaller and less numerous and were mainly present at the cell periphery (Fig. 3A, c and c′) . The quantitative analysis showed that compared with MβCD treated cells, the average number and size of focal adhesions were reduced in the presence of CD ( Fig. 3B and C) , implying that excess stress fiber formation prevents focal adhesion disassembly and lipid rafts might regulate focal adhesion disassembly via modulating actin cytoskeleton.
So far, microtubules have already been reported to play an important role in regulating focal adhesion disassembly [22] . Thus, we wanted to detect whether microtubules were also involved in lipid raftmediated focal adhesion disassembly. We first disrupted microtubules with nocodazole, and examined the dynamics of focal adhesion by labeling paxillin, another focal adhesion marker. The results showed that compared with that in control cells, the microtubules in nocodazole-treated cells depolymerized, accompanied with the appearance of robust focal adhesions ( Fig. 3D, a1 , b1, a2 and b2; E and F). When nocodazole was washed out for 30 min, microtubules regenerated completely, but focal adhesions disassembled (Fig. 3D, a3 and b3; E and F). After 3 h of nocodazole washout, microtubules and focal adhesions became stable as those in untreated cells (Fig. 3D, a4 and b4; E and F). These data indicate that the depolymerization of microtubules inhibits focal adhesion disassembly. Based on the above observations, we hypothesized that the disruption of lipid rafts might inhibit the repolymerization of microtubules only if microtubules are involved in lipid raft-mediated focal adhesion disassembly. Surprisingly, microtubule repolymerization apparently took place in the entire cells which were treated with MβCD for 30 min or 3 h after removal of nocodazole (Fig. 3D, a5 and a6) . Meanwhile, the number and size of focal adhesions greatly increased after nocodazole washout and MβCD treatment for 3 h (Fig. 3D, b6 ; E and F), suggesting that the effect of lipid raft disruption on focal adhesion disassembly is independent of microtubules. In summary, the above results indicate that the influence of lipid rafts on focal adhesion disassembly is mediated by actin cytoskeleton, but not microtubules.
Lipid raft disruption-induced stress fiber formation prevents dephosphorylation of focal adhesion proteins
It is generally accepted that dephosphorylation of focal adhesion proteins is tightly associated with the disassembly of focal adhesion [23] . To determine whether the disruption of lipid rafts could prevent the dephosphorylation of focal adhesion proteins and whether stress fiber is involved in this process, we stained A375 cells with anti-paxillin antibody and PY-20, an antibody against phosphorylation of protein tyrosine residues. As shown in Fig. 4A , the PY-20 staining in control cells exhibited small dots and colocalized with focal adhesions at cell periphery ( Fig. 4A, a, d and g) , indicating that focal adhesion proteins were tyrosine phosphorylated. Upon MβCD treatment, focal adhesions and the PY-20 stained small dots became larger and strongly colocalized throughout the cells, as shown by the merged images and the histograms, which are line-scanned profiles of fluorescence intensity of focal adhesions and PY-20 along the indicated lines (Fig. 4A, h and h′) .
When cells were treated with CD after removal of MβCD, with the disassembly of focal adhesion, PY-20 stained dots became smaller (Fig. 4A, c and f) . The distribution and intensity of the PY-20 fluorescence of GFP-vinculin containing-focal adhesions showed similar phenomenon as paxillin staining focal adhesions (Fig. S2) . These data suggest that the disruption of lipid rafts leads to excessive phosphorylation of focal adhesion proteins and stress fibers are positive regulators in this process. That is, lipid rafts can stimulate focal adhesion protein dephosphorylation via regulating the dynamics of actin cytoskeleton. To further examine the phosphorylation status of focal adhesion proteins (paxillin and vinculin), we performed immunoprecipitation experiments. The results showed that MβCD treatment greatly up-regulated the phosphorylation levels of paxillin and vinculin, but this effect was abrogated following CD treatment (Fig. 4B) . Furthermore, the tyrosine phosphorylation of vinculin was comparatively more sensitive to actin cytoskeleton dynamics than that of paxillin, which was further supported by the results of the CD treatment alone group (Fig. 4B) . These results clearly indicate that although the degrees are distinct, the dephosphorylation of both vinculin and paxillin can be triggered by lipid raftregulated actin cytoskeleton dynamics.
Lipid raft disruption-induced stress fiber formation prevents β3 integrin internalization
The internalization of integrin is thought to be an important mechanism of focal adhesion disassembly [24] . Thus, we next investigated whether lipid rafts and stress fiber can affect integrin internalization. The flow cytometry results indicated that β1 and β3 integrins are strongly expressed on the surface of A375 cells (Fig. S3 ). But the question that focal adhesion largely consists of which type of integrin subunit in A375 cells was still unknown. The confocal images in Fig. 5A revealed that β1 integrin which was either dispersedly distributed in control cells or spots-like distributed in MβCD treated cells has no colocalization with paxillin ( Fig. 5A, a-c, a′-c′) . This became more intuitive when confocal microscope software was employed to analyze the colocalization by generating white dots (Fig. 5A, d and d′) . However, β3 integrin, which was punctate at the control cell periphery, colocalized with paxillin and the colocalization was highly significant after MβCD treatment (Fig. 5A , e-h, e′-h′). We also transfected cells with GFP-vinculin plasmid, then labeled β1 and β3 integrins respectively. The results showed that similarly to paxillin, vinculin, colocalized Fig. 3A and the cells treated with CD alone were lysed, and the lysates were subjected to immunoprecipitation with the indicated antibodies. The tyrosine phosphorylation (Tyrp) of paxillin and vinculin were tested by immunoblotting with PY-20. The immunoblotting bands were quantified by densitometry using ImageJ software, and the data are normalized with respect to the control. with β3 integrin, but not β1 integrin (Fig. S4) . These results indicate that the structural basis of focal adhesion consists of β3 integrin, which closely associates with lipid raft-meditated focal adhesion dynamics in migrating A375 cells.
To further detect whether β3 integrin internalization is involved in focal adhesion disassembly, we performed antibody internalization assay. Internalized antibody-β3 integrin complexes were visualized by immunofluorescence and quantified by determining the mean fluorescence intensity per cell. The disassembly of focal adhesion was examined by staining with paxillin antibody. The results showed that antibody-β3 integrin complexes, not isotype IgG complexes, were efficiently internalized in the cells shifted from 4°C (a non-permissive temperature for internalization) to 37°C for 1 h (Fig. 5B, a, d and g;  C) . The analysis of focal adhesion number showed that compared with the cells incubated at 4°C, the number of focal adhesions in β3 integrin internalized cells significantly decreased, suggesting that the internalization of β3 integrin is tightly associated with focal adhesion disassembly (Fig. 5B, b and h; D) . Furthermore, we found that MβCD treatment for 3 h prevented β3 integrin internalization and increased the number of focal adhesions (Fig. 5B , j-l; C and D). However, CD treatment after removal of MβCD rescued the internalization of β3 integrin and disassembly of focal adhesions to some degree (Fig. 5B , m-o; C and D). To provide further evidence for the involvement of lipid rafts and stress fiber in β3 integrin internalization, we detected the distribution of β3 integrin in control, MβCD as well as MβCD + CD treated A375 cells using subcellular fractionation and flow cytometry assays. The results showed that MβCD treatment increased the distribution of β3 integrin in the membrane but this effect was partly eliminated following CD treatment ( Fig. 5E and F) . The changes in the level of β3 integrin in membrane were well correlated with the changes in the β3 integrin internalization and focal adhesion disassembly. In conclusion, these results indicate that lipid rafts can regulate focal adhesion disassembly via modulating actin cytoskeleton-mediated β3 integrin internalization.
3.6. Lipid raft disruption enhances stress fiber formation through Src-RhoA-ROCK signaling pathway
The above results indicate that the dynamics of actin cytoskeleton play an important role in lipid raft-induced focal adhesion disassembly process. Next we were interested to discover how lipid raft disruption enhances stress fiber formation. Rho GTPase family has been shown to regulate the dynamics of actin cytoskeleton [25] , thus we examined whether disruption of lipid rafts activated the members of Rho GTPase (RhoA, Rac1 and Cdc42) by using GST pull-down methods. As shown in Fig. 6A , MβCD treatment increased the amount of active RhoA but reduced that of active Rac1. The amount of active Cdc42 had no obvious change. Since RhoA, not Rac1, has been shown to regulate the formation of stress fibers [20] , it is likely that lipid rafts regulate focal adhesion disassembly via RhoA-mediated actin cytoskeleton dynamics. To test this, we transiently cotransfected A375 cells with RhoA Q63L, a constitutively active form of RhoA, and GFP. As expected, RhoA Q63L transfected cells displayed prominent stress fibers (Fig. 6B ). Furthermore, the disassembly of focal adhesions and dephosphorylation of focal adhesion proteins were also inhibited in RhoA Q63L transfected cells (Fig. 6B) . Conversely, when we pretreated cells with C3 exoenzyme, a Rho inhibitor, MβCD treatment-induced stress fiber formation was effectively prevented, bringing about focal adhesion disassembly (Fig. 6C ). The results above imply that lipid rafts regulate the dynamics and function of actin cytoskeleton via mediating RhoA activation. Downstream of RhoA is ROCK, which is activated by Rho binding. The variation tendencies of actin cytoskeleton and focal adhesion in cells treated with ROCK inhibitor-Y27632 were consistent with that in C3 exoenzyme treated cells (Fig. 6C) , indicating that the disruption of lipid rafts triggers RhoA-ROCK signaling pathway.
To further reveal the relationship between lipid rafts and RhoA activation, we isolated raft fractions and examined the location of RhoA in these fractions. Unfortunately, RhoA was found neither in the lipid raft fractions of control cells nor that of MβCD treated cells, suggesting that lipid rafts may regulate RhoA activation indirectly ( Fig. 6D ). Src, a non-receptor tyrosine kinase, has been shown to be located in lipid rafts [12] and serve as a negative regulator of RhoA activity [20] . Therefore, it is possible that cholesterol depletion releases Src and reduces its activity, which in turn promotes the activation of RhoA. To verify this hypothesis, we first detected the distribution of Src in raft and non-raft fractions in control and MβCD treated A375 cells. As shown in Fig. 6D , Src was found in lipid raft fractions in control cells, while MβCD treatment caused their delocalization from lipid raft fractions to non-raft fractions. Meanwhile, the level of phosphorylated Src, an active form of Src, in the whole cell lysate was reduced after MβCD treatment (Fig. 6E ). Taken together, the results above indicate that the formation of stress fibers in lipid raft disrupted cells is likely due to the low level of active Src, which effectively up regulates RhoA activity.
Discussion
Lipid rafts have been implicated in neurological diseases, cardiovascular diseases, immune disorders and HIV infection [26] . Although the roles of lipid rafts in cancer progression have also been reported [17, 27] , how lipid rafts affect the migration of cancer cells remains obscure.
Our study showed that lipid rafts can regulate human melanoma A375 cell migration by controlling its morphological change (Fig. 1) . The sequential morphological changes of cancer cells in migration depend on the dynamics of actin cytoskeleton and focal adhesion. Recently, some studies have indicated that the disruption of lipid rafts by MβCD treatment triggers stress fiber formation in different cancer cell lines [28, 29] . Consistent with these reports, our microscopic data demonstrate that MβCD treated A375 cells form thicker stress fiber than control cells ( Figs. 2A and S1 ). Interestingly, we also found that MβCD treatment inhibited the disassembly of focal adhesion (Fig. 2 ; Movies 3 and 4). Similar results were obtained in M21 cells, another human melanoma cell line, suggesting that the effects of lipid raft on cell migration, actin cytoskeleton arrangement and focal adhesion disassembly may be general physiological responses in human melanoma cells (Figs. S5 and S6; Movies 5 and 6).
Since actin cytoskeleton is linked to focal adhesions and regulates their stability [7] [8] [9] , we examined whether lipid rafts regulate focal adhesion disassembly via modulating actin cytoskeleton. When we treated the cells with CD after removal of MβCD, the robust stress fibers disappeared, and the number and size of focal adhesions reduced, implying that stress fiber is indeed a critical regulator in MβCD treatment-induced prevention of focal adhesion disassembly. Microtubule depolymerization has been reported to induce stress fiber formation and inhibit focal adhesion disassembly [22, 30] . Moreover, Wehrle-Haller suggested the unexcluded possibility that the depolymerization of stress fiber is the cause for microtubuleinduced focal adhesion disassembly [31] . So we asked whether lipid rafts could regulate actin cytoskeleton and focal adhesion dynamics via microtubules. However, we noticed that after nocodazole washout for 3 h, MβCD treated cells still display enhanced stress fiber formation and weakened focal adhesion disassembly, although microtubules have already fully regrown ( Fig. S7; Fig. 3D-F) . Thus, we have provided the evidence that lipid rafts regulate focal adhesion disassembly by modulating actin cytoskeleton dynamics, which is independent of microtubules.
The dephosphorylation of focal adhesion proteins and the internalization of integrin associated with the disassembly of focal adhesion have been reported previously [23, 24] . It is noteworthy that lipid rafts are well correlated with the dephosphorylation of some proteins, such as Src Homology 2 Domain-Containing Phosphatase 1 and Bad [32, 33] , and the internalization of integrin [14] . In this study, we found that disrupting lipid rafts inhibited the dephosphorylation of two main focal adhesion proteins vinculin and paxillin, and the internalization of β3 integrin through the enhancement of stress fiber. It has been demonstrated that clathrin or caveolae-dependent endocytosis can mediate the internalization of integrin [34] and be facilitated by the disruption of actin cytoskeleton [35, 36] . Our observation that lipid rafts regulate β3 integrin internalization via modulating actin cytoskeleton proves the importance of actin cytoskeleton in integrin internalization and suggests that lipid rafts may regulate β3 integrin internalization by actin cytoskeleton dependent-clathrin or caveolae-mediated endocytosis.
Considering the important roles of actin cytoskeleton in lipid raftinduced focal adhesion disassembly, it was essential to investigate how lipid rafts regulate actin cytoskeleton dynamics. The Rho GTPases, RhoA, Rac1 and Cdc42, have been reported to modulate actin cytoskeleton dynamics and cell shapes [25] . Our results show that lipid raft disruption could induce RhoA-ROCK signaling pathway that governs stress fiber formation. In cell motility, some protein kinases are thought to be important for the function of RhoA [37, 38] . One of these kinases is Src which negatively regulates RhoA activity in adhesion of metastatic melanoma cells on vitronectin [20] . It has also been indicated that the location and activation of Src in cells are intimately related to lipid rafts [12, 39] . In our study, we demonstrate that Src activation depends on its location in raft fractions in A375 cells ( Fig. 6D and E ), suggesting that lipid rafts are likely to regulate actin cytoskeleton dynamics via modulating Src activation in Src-RhoA-ROCK signaling pathway. Various cytokine and growth factor receptors, such as CXCR4 and plateletderived growth factor receptor, have been reported to be located in lipid rafts and effectively induce Src activation [40, 41] . Thus, although not been detected in our research, it is possible that lipid rafts regulate A375 cell migration by modulating membrane receptor-mediated Src activation. In the present study, we also found that the amount of active Rac1 is reduced after lipid raft disruption. Rac1 functions in inducing lamellipodia formation, so it is likely that lipid rafts can also regulate melanoma cell migration through Rac1-associated pathway.
In conclusion, we have provided evidence that lipid rafts regulate actin cytoskeletal organization and focal adhesion dynamics in melanoma cells, leading to their morphological changes during migration. Our data indicate that lipid rafts effectively regulate the dynamics of actin cytoskeleton by anchoring Src and negatively modulating RhoA activity. Lipid raft disruption leads to Src dislocation from lipid rafts and inactivity, which causes over-activation of RhoA and the formation of robust stress fiber. Following stress fiber formation, the focal adhesion protein dephosphorylation and the β3 integrin internalization are inhibited, which results in the suppression of focal adhesion disassembly (Fig. 7) . These data reveal a novel mechanism by which lipid rafts regulate focal adhesion disassembly in cancer cell migration and underscore the potential of raft-targeting agents as effective anticancer drugs.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.bbamcr.2013.09.007.
